Evidence map›Paper›PMID 39708269›Full record

ArticleJournal of neurology2024

Subtypes of cognitive impairment in cerebellar disease identified by cross-diagnostic cluster-analysis: results from a German multicenter study.

Qi Liu, Kerstin Rubarth, Jennifer Faber, Patricia Sulzer, Imis Dogan, Miriam Barkhoff, Martina Minnerop, Adam M Berlijn, Saskia Elben, Heike Jacobi and 18 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Qi LiuDepartment of Neurology, Essen University Hospital, University of Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany.
Kerstin RubarthInstitute of Biometry and Clinical Epidemiology, Charité-University Medicine Berlin, Corporate Member of Freie University, Berlin, Germany.
Jennifer FaberGerman Center for Neurodegenerative Diseases (DZNE) Bonn, Bonn, Germany.
Patricia SulzerDivision Translational Genomics of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research and Center of Neurology, Eberhard-Karls University Tübingen, Tübingen, Germany.
Imis DoganDepartment of Neurology, University Hospital RWTH Aachen, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.
Miriam BarkhoffGerman Center for Neurodegenerative Diseases (DZNE) Bonn, Bonn, Germany.
Martina MinneropDepartment of Neurology, Center for Movement Disorders and Neuromodulation, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Adam M BerlijnInstitute of Neuroscience and Medicine (INM-1), Research Center Jülich GmbH, Jülich, Germany.
Saskia ElbenDepartment of Neurology, Center for Movement Disorders and Neuromodulation, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Heike JacobiDepartment of Neurology, Heidelberg University Hospital, Ruprecht-Karls University, Heidelberg, Germany.
Julia-Elisabeth AktoriesDepartment of Neurology, Heidelberg University Hospital, Ruprecht-Karls University, Heidelberg, Germany.
Dana M HuvermannDepartment of Neurology, Essen University Hospital, University of Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany.
Friedrich ErdlenbruchDepartment of Neurology, Essen University Hospital, University of Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany.
Raquel Van der VeenDepartment of Neurology, Essen University Hospital, University of Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany.
Johanna MüllerDepartment of Neurology, Essen University Hospital, University of Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany.
Enzo NioDepartment of Neurology, Essen University Hospital, University of Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany.
Benedikt FrankDepartment of Neurology, Essen University Hospital, University of Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany.
Martin KöhrmannDepartment of Neurology, Essen University Hospital, University of Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany.
Elke WondzinskiDepartment of Neurology and Neurorehabilitation, MediClin Rhein/Ruhr, Essen, Germany.
Mario SieblerDepartment of Neurology and Neurorehabilitation, MediClin Rhein/Ruhr, Essen, Germany.
Kathrin ReetzDepartment of Neurology, University Hospital RWTH Aachen, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.
Jürgen KonczakHuman Sensorimotor Control Laboratory, School of Kinesiology and Center for Clinical Movement Science, University of Minnesota, Minneapolis, USA.
Frank KonietschkeInstitute of Biometry and Clinical Epidemiology, Charité-University Medicine Berlin, Corporate Member of Freie University, Berlin, Germany.
Thomas KlockgetherGerman Center for Neurodegenerative Diseases (DZNE) Bonn, Bonn, Germany.
Matthis SynofzikDivision Translational Genomics of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research and Center of Neurology, Eberhard-Karls University Tübingen, Tübingen, Germany.
Sandra RöskeGerman Center for Neurodegenerative Diseases (DZNE) Bonn, Bonn, Germany.
Dagmar TimmannDepartment of Neurology, Essen University Hospital, University of Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany.
Andreas ThiemeDepartment of Neurology, Essen University Hospital, University of Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany. andreas.thieme@uk-essen.de.ORCID http://orcid.org/0000-0001-6221-8601

Funding

Deutsche Forschungsgemeinschaft 437661157The State Scholarship Fund of China 202308110231UMEA/ DFG (University Medicine Essen Clinician Scientist Academy - a program funded by Deutsche Forschungsgemeinschaft, German Research Foundation) FU356/12-1
6 · The paper itself

Abstract

backgroundCognitive and neuropsychiatric impairment, known as cerebellar cognitive affective syndrome (CCAS), may be present in cerebellar disorders. This study identified distinct CCAS subtypes in cerebellar patients using cluster analysis.

methodsThe German CCAS-Scale (G-CCAS-S), a brief screening test for CCAS, was assessed in 205 cerebellar patients and 200 healthy controls. K-means cluster analysis was applied to G-CCAS-S data to identify cognitive clusters in patients. Demographic and clinical variables were used to characterize the clusters. Multiple linear regression quantified their relative contribution to cognitive performance. The ability of the G-CCAS-S to correctly distinguish between patients and controls was compared across the clusters.

resultsTwo clusters explained the variance of cognitive performance in patients' best. Cluster 1 (30%) exhibited severe impairment. Cluster 2 (70%) displayed milder dysfunction and overlapped substantially with that of healthy controls. Cluster 1 patients were on average older, less educated, showed more severe ataxia and more extracerebellar involvement than cluster 2 patients. The cluster assignment predicted cognitive performance even after adjusting for all other covariates. The G-CCAS-S demonstrated good discriminative ability for cluster 1, but not for cluster 2.

conclusionsThe variance of cognitive impairment in cerebellar disorders is best explained by one severely affected and one mildly affected cluster. Cognitive performance is not only predicted by demographic/clinical characteristics, but also by cluster assignment itself. This indicates that factors that have not been captured in this study likely have effects on cognitive cerebellar functions. Moreover, the CCAS-S appears to have a relative weakness in identifying patients with only mild cognitive deficits. STUDY REGISTRATION: The study has prospectively been registered at the German Clinical Study Register ( https://www.drks.de ; DRKS-ID: DRKS00016854).

Indexed as

Cerebellar DiseasesCognitive DysfunctionAdultAgedCluster AnalysisFemaleGermanyHumansMaleMiddle AgedNeuropsychological TestsCerebellar cognitive affective syndrome (CCAS)Cerebellar disordersCluster analysisGerman CCAS-ScaleSubgroups of CCAS

Identifiers

PMID39708269
PMCPMC11663179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.